Growing Inclination of Mobile Apps for DNA Sequencing: Global Markets
Press Release – 08
Jan 2019
Research
and Development News
--
.
.
Latest
Update
"Mobile Apps for DNA Sequencing: Global Markets"
with Industries Survey | Global Current Growth and Future.
'
'
The global market for mobile applications for DNA
sequencing reached $28.8 billion in 2017. The market should reach
$248.3 billion by 2022, at a compound annual growth rate (CAGR) of
53.8% during 2017-2022.
Report Includes:
- An in-depth analysis of the mobile applications
of DNA sequencing, which is a developing personalized healthcare
technique with enormous market potential.
- Analyses of market trends, with data from 2016
and 2017, and projections of compound annual growth rates (CAGRs)
through 2022
'
'
-
A look at the current and future expectations regarding the cost of
individual DNA mapping procedures
-
Quantification of the DNA sequencing markets by product type,
indication, and geography
-
Insight into developers of apps, and how DNA mapping and apps combine
to produce modern ways of recording information
-
Comprehensive discussion covering DNA sequencing technologies, market
applications, industry structure, and important clinical sequencing
initiatives
Patent analysis
Patent analysis
- Company
profiles of major players in the DNA sequencing sector, including
23andMe, Helix, Illumina, Thermo Fisher Scientific, and Roche
“Report
Scope”
This report is a comprehensive business tool, designed to provide an in-depth look at mobile applications of DNA sequencing. The geographical scope of the report is global, with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare sector and its participants and trends for the future.
This report is a comprehensive business tool, designed to provide an in-depth look at mobile applications of DNA sequencing. The geographical scope of the report is global, with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare sector and its participants and trends for the future.
Areas discussed include current funding being
provided by the National Institutes of Health (NIH) in the U.S. and
the National Health Service (NHS) in the U.K., which are at the
forefront of this developing market. Funding worldwide is discussed
in this report, together with the thought processes behind applying
precision medicine to healthcare services.
Clinical trials are discussed in the report,
together with developing technologies, software and cloud data
storage, which are driving the translational science market for
future precision medicine healthcare.
Categories discussed in the report include
applications of:
- DNA sequencing/mapping.
- Genome sequencing/mapping.
- Gene sequencing/mapping.
- Exome sequencing.
- Metagenomics.
- Targeted sequencing.
– For
Other Requirement and Enquiry_
https://www.researchmoz.us/enquiry.php?type=E&repid=1532654
'
'
Devices for
individual use, which in the main use Android or iOS operating
systems, are discussed briefly. While the device market is not
specifically part of this report, the developing technology will be
used for the future of this market, including:
- iPads.
- PCs.
- PCs.
The end-use segments discussed in the report are:
Genealogy.
- Computational biology/rare diseases.
Categories, platform segments and regions are discussed in detail, including describing and identifying current products on the market, measuring the market size, and market drivers with a forecast to 2022. Competitors are assessed, together with their respective market shares. For the country-level breakdown of segments, only the base year 2017 and projections to 2022 are indicated in the data in the tables. Year-to-year differences are considered as statistically insignificant.
Categories, platform segments and regions are discussed in detail, including describing and identifying current products on the market, measuring the market size, and market drivers with a forecast to 2022. Competitors are assessed, together with their respective market shares. For the country-level breakdown of segments, only the base year 2017 and projections to 2022 are indicated in the data in the tables. Year-to-year differences are considered as statistically insignificant.
The market evaluation in the study pertains to
existing processes and/or devices used in the mobile application of
DNA sequencing, and which have been developed and approved for human
clinical use. The market size takes this into account.
Options/upgrades or refurbished/remarketed equipment has not been
accounted for in the quantitative estimates and forecasts provided in
the study. Ancillary products and services also related to the
application of DNA sequencing conditions are discussed. Metrics
countrywide, using information at the country level to look at the
dynamics and their impact on reviews and growth, are used. Interviews
were used to confirm and/or adjust the U.S. market size and market
share estimates, as well as formulating market projections.
This report concentrates on the processes behind
DNA sequencing techniques and discusses the developers of DNA
sequencing and mobile applications of DNA sequencing and the history,
processes and future developments being used to create and develop
mobile applications.
Included in the report is a general overview of
the genetic processes and terms used in the main areas of genomic
studies and preparations. The report provides an outline only of the
main areas involved with DNA sequencing.
This is a new market moving forward into
revolutionary global healthcare through precision medicine. This
report therefore reflects the new apps that have just become
available in the market, together with developing technology.
Clinical trials pertaining to moving toward the new global healthcare
of precision medicine is studied in this report.
Included in the report is the developing market in
the bioinformatics field of genetics and translational medicine from
current standard medical practices to medical practices involving
computational biology. Some devices studied in the report touch on
the current and future market. The devices forecasted in the report
are those that pertain to the current developing mobile apps market.
Specifically excluded from the study, as it is
considered beyond the scope of the report, is an in-depth study of
individuals who have had their DNA sequenced or mapped. Also excluded
from the report is a detailed, in-depth study of the types of
technology and methodology and terminology used, although this is
outlined in general. Also excluded from the report is a detailed
study of all the processes involved in genetics/genomes/sequencing as
this topic is too vast in itself to explore in this report.
Also excluded from the report is a detailed
description of all types of DNA sequencing, although the main areas
in this topic are discussed, a further detailed in-depth examination
of DNA sequencing is not deemed to be necessary for market values.
Considered outside the scope of this report is a
detailed study of current mobile device technology, such as Android
phones, PCs or tablets, as this report does not concentrate on this
side of technological developments.
Continue.....
– More
Clear Details get Full Table of Contents_
https://www.researchmoz.us/mobile-apps-for-dna-sequencing-global-markets-report.html/toc
About
Researchmoz,
ResearchMoz
is the world’s fastest growing collection of market research
reports worldwide. Our database is composed of current market studies
from over 100 featured publishers worldwide. Our market research
databases integrate statistics with analysis from global, regional,
country and company perspectives. ResearchMoz’s service portfolio
also includes value-added services such as market research
customization, competitive landscaping, and in-depth surveys,
delivered by a team of experienced Research
Coordinators.
--Researchmoz Global Pvt. Ltd.--
--Researchmoz Global Pvt. Ltd.--
Mr.
Nachiket G.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
Comments
Post a Comment